Quantification of vessel wall contrast enhancement to monitor disease progression in Moyamoya disease

• S.S.-Y. Wang,
• H. Hurth,
• P. Haas,
• B. Bender,
• U. Ernemann,
• M.S. Tatagiba,
• N. Khan,
• C. Roder

Affiliations

S.S.-Y. Wang

Eberhard Karls University, Neurosurgery and Neurotechnology, Tuebingen, Germany; University Hospital Tuebingen, Moyamoya and cerebral Revascularisazion Center, Tuebingen, Germany

H. Hurth

Eberhard Karls University, Neurosurgery and Neurotechnology, Tuebingen, Germany; University Hospital Tuebingen, Moyamoya and cerebral Revascularisazion Center, Tuebingen, Germany

P. Haas

Eberhard Karls University, Neurosurgery and Neurotechnology, Tuebingen, Germany; University Hospital Tuebingen, Moyamoya and cerebral Revascularisazion Center, Tuebingen, Germany

B. Bender

Eberhard Karls University, Neuroradiology, Tuebingen, Germany

U. Ernemann

Eberhard Karls University, Neuroradiology, Tuebingen, Germany

M.S. Tatagiba

Eberhard Karls University, Neurosurgery and Neurotechnology, Tuebingen, Germany

N. Khan

University Children Hospital Zurich, Zurich, Switzerland; University Hospital Tuebingen, Moyamoya and cerebral Revascularisazion Center, Tuebingen, Germany

C. Roder

Eberhard Karls University, Neurosurgery and Neurotechnology, Tuebingen, Germany; University Hospital Tuebingen, Moyamoya and cerebral Revascularisazion Center, Tuebingen, Germany